By bioinformatics analyses, 7 key targets of JLD treatment for T2DM (AKT1, TNF, IL-6, TP53, PTGS2, CASP3 and STAT3) were obtained. The gene discussed is PTGS2; the disease is type 2 diabetes mellitus.